256 related articles for article (PubMed ID: 16391868)
21. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
22. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of cytokeratin-positive bone marrow cells of gastric cancer patients.
Gretschel S; Schick C; Schneider U; Estevez-Schwarz L; Bembenek A; Schlag PM
Ann Surg Oncol; 2007 Feb; 14(2):373-80. PubMed ID: 17080240
[TBL] [Abstract][Full Text] [Related]
24. [Cytokeratin 20 as a marker of tumor progression or dissemination in patients with colorectal cancer].
Garrido S M; Ramírez V P; Risueño A C; Orellana U E; Galindo A H; Alvarez Z M
Rev Med Chil; 2008 Apr; 136(4):482-90. PubMed ID: 18769791
[TBL] [Abstract][Full Text] [Related]
25. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome.
Hamady ZZ; Malik HZ; Alwan N; Wyatt JI; Prasad KR; Toogood GJ; Lodge JP
Eur J Surg Oncol; 2008 Feb; 34(2):180-4. PubMed ID: 17983724
[TBL] [Abstract][Full Text] [Related]
26. Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients.
De Cremoux P; Grandin L; Diéras V; Savignoni A; Degeorges A; Salmon R; Bollet MA; Reyal F; Sigal-Zafrani B; Vincent-Salomon A; Sastre-Garau X; Magdelénat H; Mignot L; Fourquet A;
Anticancer Res; 2009 May; 29(5):1475-82. PubMed ID: 19443353
[TBL] [Abstract][Full Text] [Related]
27. An MVA-based vaccine targeting the oncofetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastases.
Elkord E; Dangoor A; Drury NL; Harrop R; Burt DJ; Drijfhout JW; Hamer C; Andrews D; Naylor S; Sherlock D; Hawkins RE; Stern PL
J Immunother; 2008; 31(9):820-9. PubMed ID: 18833005
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis and treatment of colorectal liver metastases - workflow].
Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
[TBL] [Abstract][Full Text] [Related]
29. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
[TBL] [Abstract][Full Text] [Related]
30. uPA and PAI-1 in rectal cancer--relationship to radiotherapy and clinical outcome.
Angenete E; Langenskiöld M; Palmgren I; Falk P; Oresland T; Ivarsson ML
J Surg Res; 2009 May; 153(1):46-53. PubMed ID: 18533186
[TBL] [Abstract][Full Text] [Related]
31. Presence of microsatellite lesions with colorectal liver metastases correlate with intrahepatic recurrence after surgical resection.
Hayashi H; Nabeshima K; Hamasaki M; Yamashita Y; Shirakusa T; Iwasaki H
Oncol Rep; 2009 Mar; 21(3):601-7. PubMed ID: 19212617
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases].
He YF; Li YH; Zhang DS; Xiang XJ; Xu RH; Pan ZZ; Zhou ZW; Jiang WQ; He YJ; Wan DS
Ai Zheng; 2006 Sep; 25(9):1153-7. PubMed ID: 16965661
[TBL] [Abstract][Full Text] [Related]
33. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center.
Carpizo DR; Are C; Jarnagin W; Dematteo R; Fong Y; Gönen M; Blumgart L; D'Angelica M
Ann Surg Oncol; 2009 Aug; 16(8):2138-46. PubMed ID: 19495884
[TBL] [Abstract][Full Text] [Related]
34. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients.
Gold JS; Are C; Kornprat P; Jarnagin WR; Gönen M; Fong Y; DeMatteo RP; Blumgart LH; D'Angelica M
Ann Surg; 2008 Jan; 247(1):109-17. PubMed ID: 18156930
[TBL] [Abstract][Full Text] [Related]
35. The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases.
Martinez SR; Young SE; Giuliano AE; Bilchik AJ
Am J Surg; 2006 Feb; 191(2):281-3. PubMed ID: 16442961
[TBL] [Abstract][Full Text] [Related]
36. Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases.
Bennett JJ; Schmidt CR; Klimstra DS; Grobmyer SR; Ishill NM; D'Angelica M; DeMatteo RP; Fong Y; Blumgart LH; Jarnagin WR
Ann Surg Oncol; 2008 Apr; 15(4):1130-6. PubMed ID: 18228106
[TBL] [Abstract][Full Text] [Related]
37. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
38. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
[TBL] [Abstract][Full Text] [Related]
39. Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis?
Sarpel U; Bonavia AS; Grucela A; Roayaie S; Schwartz ME; Labow DM
Ann Surg Oncol; 2009 Feb; 16(2):379-84. PubMed ID: 19020941
[TBL] [Abstract][Full Text] [Related]
40. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
